GGrantIndex
Sort

172,184 grants matching inflammation

HIV Neurobehavioral Research Center

$1,499,994
David J Moore · University Of California, San Diego · P30 · FY2023 · MH

HIV Neurobehavioral Research Center

$1,499,994
David J Moore · University Of California, San Diego · P30 · FY2024 · MH

HIV Neurobehavioral Research Center

$1,499,994
David J Moore · University Of California, San Diego · P30 · FY2025 · MH

HIV Neurobehavioral Research Center

$1,499,994
Robert Kernachan Heaton · University Of California, San Diego · P30 · FY2022 · MH

Automation of Extracorporeal Filtration of Subarachnoid Hemorrhage via Spinal Catheter

$1,499,976
Aaron Richard McCabe · Minnetronix, Inc. · R44 · FY2020 · NS

Intestinal bacterial metagenome in pediatric NAFLD

$1,499,969
Nita H Salzman · Medical College Of Wisconsin · R01 · FY2012 · DK

Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain

$1,499,931
Xinmin Simon Xie · Afasci, Inc. · R44 · FY2024 · NS

Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain

$1,499,931
Xinmin Simon Xie · Afasci, Inc. · R44 · FY2023 · NS

IGF::OT::IGF: SBIR PHASE II, TOPIC 331: OPTICAL BIOSENSOR FOR REAL-TIME ASSESSMENT OF TUMOR CELLULARITY DURING CORE NEEDLE BIOPSY PROCEDURES.

$1,499,725
Nicusor Iftimia · Physical Sciences, Inc · N44 · FY2016 · CA

Development of modified human thioredoxin as an inhaled biologic therapeutic for cystic fibrosis

$1,499,635
Peter B Heifetz · Orpro Therapeutics, Inc. · R44 · FY2018 · HL

Therapeutic antibody for RSV

$1,499,589
Lawrence Michael Kauvar · Trellis Bioscience, Inc. · R44 · FY2017 · AI

Comprehensive Sickle Cell Center

$1,499,547
Clinton H. Joiner · Cincinnati Childrens Hosp Med Ctr · U54 · FY2009 · HL

Development of Novel Intra-aneurysmal Rapid Occlusion Device

$1,499,517
Stephen J Hebert · Neurogami Medical, Inc. · R44 · FY2021 · NS

A Controlled Trial of CBT for MS Inflammation

$1,499,399
David I. Daikh · Northern California Institute/Res/Edu · R01 · FY2006 · HD

Clinical and Mechanistic Investigations of Salivary Gland Dysfunction

$1,499,358
Blake Warner · National Institute Of Dental & Craniofacial Research · ZIA · FY2021 · DE

Development of Novel Intra-aneurysmal Rapid Occlusion Device

$1,499,299
Stephen J Hebert · Neurogami Medical, Inc. · R44 · FY2020 · NS

Metabolic pathways linked to immunity

$1,499,102
Michael Sack · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

PHYSICAL ACTIVITY, OBESITY, INFLAMMATION AND CHD IN MULTI-ETHNIC COHORT OF WOMEN

$1,499,019
I-Min Lee · · N01 · FY2007 · WH

Gene networks controlling macrophage-adipocyte interactions in insulin resistance

$1,498,959
Christopher K Glass · University Of California, San Diego · P01 · FY2010 · DK

NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence

$1,498,944
Howard Eliot Gendelman · University Of Nebraska Medical Center · P01 · FY2013 · DA

The Role Of Nrf2 In Susceptibility To Hyperoxic Lung Injury

$1,498,900
Steven R Kleeberger · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES

Structural Studies of Pattern Recognition Receptors

$1,498,876
Tsan Xiao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

SMART Use of Biologics in Chronic Rhinosinusitis with Nasal Polyposis

$1,498,642
Timothy L Smith · Oregon Health & Science University · U01 · FY2025 · AI

Michigan Center on Lifestage Environmental Exposures and Disease

$1,498,503
Dana Dolinoy · University Of Michigan At Ann Arbor · P30 · FY2020 · ES

Mitochondrial DNA and Sex Differences in Scleroderma-Associated ILD

$1,498,380
Erica L Herzog · Yale University · R01 · FY2025 · HL